Pricing Log in Create free account

eXoZymes Inc. (EXOZ) vs Hyperion DeFi, Inc. (HYPD)

eXoZymes Inc. and Hyperion DeFi, Inc. are both Biotechnology companies. eXoZymes Inc. and Hyperion DeFi, Inc. are of similar size ($39.8M and $38.1M). eXoZymes Inc. has the higher net margin (0.00% vs −1,224.5%) and the lower return on invested capital (0.00% vs 2.73%). Across the 13 metrics below, Hyperion DeFi, Inc. leads on 7 and eXoZymes Inc. on 6.

Valuation

Metric EXOZ HYPD Biotechnology median
P/E n/m n/m 10.60
P/S n/m 25.50 9.40
P/B 10.43 0.35 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 7.06 0.66
EV/Sales n/m 24.64 9.02
Earnings yield (27.05%) (245.63%) (32.88%)
Free cash flow yield (18.74%) (216.06%) (23.13%)

Profitability

Metric EXOZ HYPD Biotechnology median
Gross margin — 78.35% 68.51%
Operating margin 0.00% 314.32% 0.00%
Net margin 0.00% (1,224.53%) 0.00%
Free cash flow margin 0.00% (5,509.35%) 0.00%
Return on equity (187.16%) (24.63%) (51.96%)
Return on assets (115.42%) (20.32%) (46.06%)
Return on invested capital 0.00% 2.73% 0.00%

Growth

Metric EXOZ HYPD Biotechnology median
Revenue growth (TTM) — 1,990.60% 6.76%
EPS growth (last fiscal year) (22.47%) 84.28% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric EXOZ HYPD Biotechnology median
Debt to equity 0.01 0.08 0.00
Current ratio 3.81 2.34 4.97
Net debt to EBITDA 0.31 (0.03) 1.01

Dividend

Metric EXOZ HYPD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric EXOZ HYPD Biotechnology median
Market cap 38.14m 39.78m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack